These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18167195)

  • 1. A winning war against hepatitis B virus infection in China.
    Jia JD; Zhuang H
    Chin Med J (Engl); 2007 Dec; 120(24):2157-8. PubMed ID: 18167195
    [No Abstract]   [Full Text] [Related]  

  • 2. [Viral hepatitis B vaccine prevention and it related problem in China].
    Liu CB; Su CA
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):377-8. PubMed ID: 15231154
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiological study of hepatitis B in 1990-2003 in Wuxi City, Jiangsu Province].
    Lin YT; Liu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1083. PubMed ID: 15769373
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China.
    Liang X; Bi S; Yang W; Wang L; Cui G; Cui F; Zhang Y; Liu J; Gong X; Chen Y; Wang F; Zheng H; Wang F; Guo J; Jia Z; Ma J; Wang H; Luo H; Li L; Jin S; Hadler SC; Wang Y
    J Infect Dis; 2009 Jul; 200(1):39-47. PubMed ID: 19469708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis B vaccine prevention of the non-newborn populations in Beijing area].
    Xing YL; Gong XH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):381-4. PubMed ID: 15231156
    [No Abstract]   [Full Text] [Related]  

  • 6. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    Dong Y; Liu SL; Zhai XJ; Zhu FC; Pan H; Yu JX; Chen YZ; Xie YR; Zhang XY; Zhang HM; Li LJ; Wang H; Ruan B
    J Med Virol; 2009 Sep; 81(9):1517-24. PubMed ID: 19626618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Strengthen hepatitis B vaccination in populations other than newborn babies].
    Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):376. PubMed ID: 15231153
    [No Abstract]   [Full Text] [Related]  

  • 9. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the prevalence rate and immunity of hepatitis B virus infection among urban adults aged over 20 years in Wuxi, Jiangsu province].
    Qian YH; Lin YD; Shen HB; Dong MH; Deng Y; Miao XL; Wang XW; Gu J; Chen F; Yu RB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):783-6. PubMed ID: 19103114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against hepatitis B and C: towards therapeutic application.
    Inchauspe G; Bach G; Martin P; Bonnefoy JY
    Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges.
    Averhoff F; Kolwaite A; Ward JW
    Vaccine; 2013 Dec; 31 Suppl 9():J5-7. PubMed ID: 23623862
    [No Abstract]   [Full Text] [Related]  

  • 13. [Technical guide for adult hepatitis B immunization in China].
    Cui FQ; ;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Dec; 32(12):1199-203. PubMed ID: 22336599
    [No Abstract]   [Full Text] [Related]  

  • 14. The benefit-risk politics of vaccination against hepatitis B virus.
    Degos F
    Ital J Gastroenterol Hepatol; 1999; 31(5):392-4. PubMed ID: 10470599
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vaccination against Hepatitis B Virus in chronic renal disease patients].
    Franco E; Senatore S; Ruggiero F; Papa R; Zaratti L
    Ig Sanita Pubbl; 2008 Jan; 64(1):131-6. PubMed ID: 18379610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hepatitis B in China.
    Lu FM; Zhuang H
    Chin Med J (Engl); 2009 Jan; 122(1):3-4. PubMed ID: 19187608
    [No Abstract]   [Full Text] [Related]  

  • 17. [A nested case control study for risk factors impacting hepatitis B vaccination in Hebei, China].
    Ma JC; Han CZ; Qi SX; Tian C; Li J; Zhao SJ; Zhang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):201-4. PubMed ID: 19031703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination and injecting drug use: narrowing the efficacy-effectiveness gap.
    Maher L
    Int J Drug Policy; 2008 Dec; 19(6):425-8. PubMed ID: 18289840
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of hepatitis B in China: achievements and challenges.
    Lu FM; Zhuang H
    Chin Med J (Engl); 2009 Dec; 122(24):2925-7. PubMed ID: 20137475
    [No Abstract]   [Full Text] [Related]  

  • 20. The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination.
    Nothdurft HD; Dahlgren AL; Gallagher EA; Kollaritsch H; Overbosch D; Rummukainen ML; Rendi-Wagner P; Steffen R; Van Damme P;
    J Travel Med; 2007; 14(3):181-7. PubMed ID: 17437475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.